Chi Wang
Impact in
- Cancer Research top 2%
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 2%
- Epigenetics and DNA Methylation
- Protein Degradation and Inhibitors
- Gene expression and cancer classification
- Ubiquitin and proteasome pathways
Papers in
-
- Cancer, Lipids, and Metabolism 11
- Cancer, Hypoxia, and Metabolism 8
-
- Gene expression and cancer classification 20
- Metabolomics and Mass Spectrometry Studies 8
- Epigenetics and DNA Methylation 8
- Wnt/β-catenin signaling in development and cancer 7
- Co-authors
- Bernard Mark Evers (35 shared papers)Heidi L. Weiss (29 shared papers)Tianyan Gao (18 shared papers)Daheng He (41 shared papers)Hao Wu (4 shared papers)Binhua Peter Zhou (7 shared papers)Jinpeng Liu (45 shared papers)Zhijin J. Wu (2 shared papers)
- Journals
- Cancer Research (7 papers)BMC Bioinformatics (6 papers)PLoS ONE (6 papers)Nature Communications (6 papers)Cancers (5 papers)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Chi Wang
178 papers receiving 5.7k citations
Chi Wang's Hit Papers
Peers
Comparison fields: 5 of 158
- Cancer Research 876
- Molecular Biology 2.4k
- Oncology 776
- Ophthalmology 161
- Immunology and Allergy 77
Countries citing papers authored by Chi Wang
This map shows the geographic impact of Chi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi Wang more than expected).
Fields of papers citing papers by Chi Wang
This network shows the impact of papers produced by Chi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi Wang. The network helps show where Chi Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Chi Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 187 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Na/K-ATPase Y260 Phosphorylation–mediated Src Regulation in Control of Aerobic Glycolysis and Tumor Growth Hit paper breakdown → | 2018 | 491 |
| 2 | 2014 | 414 | |
| 3 | 2008 | 193 | |
| 4 | 2018 | 189 | |
| 5 | 2012 | 188 | |
| 6 | 2012 | 171 | |
| 7 | 2013 | 152 | |
| 8 | 2009 | 148 | |
| 9 | 2017 | 120 | |
| 10 | 2018 | 111 | |
| 11 | 2016 | 106 | |
| 12 | 2020 | 103 | |
| 13 | 2012 | 102 | |
| 14 | 2020 | 92 | |
| 15 | 2018 | 91 | |
| 16 | 2018 | 86 | |
| 17 | 2020 | 85 | |
| 18 | 2012 | 84 | |
| 19 | 2022 | 83 | |
| 20 | 2014 | 80 |
About Chi Wang
Chi Wang is a scholar working on Cancer Research, Molecular Biology, Oncology, Statistics and Probability and Pulmonary and Respiratory Medicine, having authored 187 papers that have together received 5.8k indexed citations. Recurring topics across this work include Gene expression and cancer classification (20 papers), Prostate Cancer Treatment and Research (13 papers), Cancer, Lipids, and Metabolism (11 papers), Cancer, Hypoxia, and Metabolism (8 papers), Cell Adhesion Molecules Research (8 papers), Metabolomics and Mass Spectrometry Studies (8 papers), Epigenetics and DNA Methylation (8 papers) and Wnt/β-catenin signaling in development and cancer (7 papers). The work is most often cited by research in Cancer Research (876 citations), Molecular Biology (2.4k citations), Oncology (776 citations), Ophthalmology (161 citations) and Immunology and Allergy (77 citations). Chi Wang has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Bernard Mark Evers, Heidi L. Weiss, Tianyan Gao, Daheng He, Hao Wu, Binhua Peter Zhou, Jinpeng Liu, Zhijin J. Wu, Yekaterina Y. Zaytseva and Yadi Wu. Their work appears in journals such as Cancer Research, BMC Bioinformatics, PLoS ONE, Nature Communications and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.